Induced abortion.
ESHRE Capri Workshop Group.
Hum Reprod. 2017 Jun 1;32(6):1160-1169. doi: 10.1093/humrep/dex071.
Outcomes of incomplete abortion related to treatment modality.
Sharvit M, Yagur Y, Shams R, Daykan Y, Klein Z, Schonman R.
Arch Gynecol Obstet. 2023 Nov;308(5):1543-1548. doi: 10.1007/s00404-023-07182-7. Epub 2023 Aug 31.
Surgical Management of Incomplete Abortion by Manual Vacuum Aspiration (MVA).
Chowdhury M, Rahman D.
Mymensingh Med J. 2019 Oct;28(4):900-905.
Evaluation of different doses of Femoston therapy for incomplete abortion: A prospective observational trial.
Wang W, Gong B, Cai Y, Huang X, An J.
Medicine (Baltimore). 2023 Oct 27;102(43):e35415. doi: 10.1097/MD.0000000000035415.
Dan'e fukang decoction reduces hemorrhage in a rat model of mifepristone induced incomplete abortion and may correlate with cell adhesion molecule signaling interference.
Ni QC, Zhong RH, Yang Y, Li GT, Yang WJ, Zhou JY, Hu YY, Wu J, Zhu Y.
J Ethnopharmacol. 2025 Jan 30;337(Pt 3):118984. doi: 10.1016/j.jep.2024.118984. Epub 2024 Oct 24.
Integrative transcriptomics and proteomics analyses to reveal the therapeutic effect and mechanism of Buxue Yimu Pills in medical-induced incomplete abortion rats.
Zhang LL, Sheng F, Yang Y, Hu YF, Li W, Huang GY, Wu MY, Gong Y, Zhang P, Zou L.
J Ethnopharmacol. 2023 Apr 6;305:116113. doi: 10.1016/j.jep.2022.116113. Epub 2022 Dec 26.
Health care providers' perceptions of using misoprostol in the treatment of incomplete abortion in Malawi.
Wagenheim CA, Savosnick H, Chakhame BM, Darj E, Kafulafula UK, Maluwa A, Odland JØ, Odland ML.
BMC Health Serv Res. 2022 Dec 3;22(1):1471. doi: 10.1186/s12913-022-08878-3.
Introducing misoprostol for treatment of incomplete abortion: A feasibility and acceptability study in secondary-level health facilities in Myanmar.
Mary M, Tin KN, Maung TM, Maung HN, Ku SK, Winikoff B.
Sex Reprod Healthc. 2023 Jun;36:100825. doi: 10.1016/j.srhc.2023.100825. Epub 2023 Feb 16.
Evaluating women's acceptability of treatment of incomplete second trimester abortion using misoprostol provided by midwives compared with physicians: a mixed methods study.
Atuhairwe S, Hanson C, Atuyambe L, Byamugisha J, Tumwesigye NM, Ssenyonga R, Gemzell-Danielsson K.
BMC Womens Health. 2022 Nov 5;22(1):434. doi: 10.1186/s12905-022-02027-y.
Effectiveness of misoprostol as an incomplete abortion treatment when given by midwives as opposed to doctors: A systematic review with meta-analysis.
Pawar N, Kaur R, Sandeep M, Shamim MA, Thampy P, Verma P, Gandhi AP, Padhi BK.
Midwifery. 2025 Sep;148:104527. doi: 10.1016/j.midw.2025.104527. Epub 2025 Jul 16.
